Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,115 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Rationale and study design for a multicenter, randomized, double-blind, placebo-controlled study of the effects of tolvaptan on the acute and chronic outcomes of patients hospitalized with worsening congestive heart failure.
Gheorghiade M, Gattis WA, Barbagelata A, Adams KF Jr, Elkayam U, Orlandi C, O'Connor CM; Acute and Chronic Therapeutic Impact of a Vasopressin Antagonist in Congestive Heart Failure Investigators. Gheorghiade M, et al. Am Heart J. 2003 Feb;145(2 Suppl):S51-4. doi: 10.1067/mhj.2003.154. Am Heart J. 2003. PMID: 12594452 Clinical Trial. No abstract available.
Rationale and design of the pilot randomized study of nesiritide versus dobutamine in heart failure (PRESERVD-HF).
Gheorghiade M, Gattis WA, Adams KF Jr, Jaffe AS, O'Connor CM; Pilot Randomized Study of Nesiritide versus Dobutamine in Heart Failure; Duke University Cooperative Cardiovascular Studies Investigators. Gheorghiade M, et al. Am Heart J. 2003 Feb;145(2 Suppl):S55-7. doi: 10.1067/mhj.2003.155. Am Heart J. 2003. PMID: 12594453 Clinical Trial. No abstract available.
Rationale and design of the Initiation Management Predischarge: Process for Assessment of Carvedilol Therapy for Heart Failure (IMPACT-HF) study.
Gheorghiade M, Gattis WA, Lukas MA, O'Connor CM; Initiation Management Predischarge: Process for Assessment of Carvedilol Therapy for Heart Failure Investigators. Gheorghiade M, et al. Am Heart J. 2003 Feb;145(2 Suppl):S60-1. doi: 10.1067/mhj.2003.157. Am Heart J. 2003. PMID: 12594455 Clinical Trial. No abstract available.
Surrogate end points in heart failure trials.
Gheorghiade M, Adams KF Jr, Gattis WA, Teerlink JR, Orlandi C, O'Connor CM. Gheorghiade M, et al. Am Heart J. 2003 Feb;145(2 Suppl):S67-70. doi: 10.1067/mhj.2003.159. Am Heart J. 2003. PMID: 12594457 No abstract available.
1,115 results